This report aims to provide a comprehensive presentation of the global market for Passive Transdermal Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Passive Transdermal Drug Delivery. This report contains market size and forecasts of Passive Transdermal Drug Delivery in global, including the following market information:
Global Passive Transdermal Drug Delivery Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Passive Transdermal Drug Delivery Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Passive Transdermal Drug Delivery companies in 2022 (%)
The global Passive Transdermal Drug Delivery market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Microfluidics Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Passive Transdermal Drug Delivery include 3M, Actavis, Inc., Bayer AG, Boehringer Ingelheim GmbH, Corium International, Inc., Echo Therapeutics, Inc., GlaxoSmithKline plc, Johnson & Johnson (Janssen Pharmaceuticals Inc.) and Mylan N.V., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Passive Transdermal Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Passive Transdermal Drug Delivery Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Passive Transdermal Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Microfluidics
Smart Pill Technology (SPT)
Global Passive Transdermal Drug Delivery Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Passive Transdermal Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Clinic
Hospital
Others
Global Passive Transdermal Drug Delivery Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Passive Transdermal Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Passive Transdermal Drug Delivery revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Passive Transdermal Drug Delivery revenues share in global market, 2022 (%)
Key companies Passive Transdermal Drug Delivery sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Passive Transdermal Drug Delivery sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
Novartis AG
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Passive Transdermal Drug Delivery, market overview.
Chapter 2: Global Passive Transdermal Drug Delivery market size in revenue and volume.
Chapter 3: Detailed analysis of Passive Transdermal Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Passive Transdermal Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Passive Transdermal Drug Delivery capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Passive Transdermal Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Passive Transdermal Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Passive Transdermal Drug Delivery Overall Market Size
2.1 Global Passive Transdermal Drug Delivery Market Size: 2022 VS 2030
2.2 Global Passive Transdermal Drug Delivery Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Passive Transdermal Drug Delivery Sales: 2018-2030
3 Company Landscape
3.1 Top Passive Transdermal Drug Delivery Players in Global Market
3.2 Top Global Passive Transdermal Drug Delivery Companies Ranked by Revenue
3.3 Global Passive Transdermal Drug Delivery Revenue by Companies
3.4 Global Passive Transdermal Drug Delivery Sales by Companies
3.5 Global Passive Transdermal Drug Delivery Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Passive Transdermal Drug Delivery Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Passive Transdermal Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 Passive Transdermal Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 Passive Transdermal Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 Passive Transdermal Drug Delivery Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Passive Transdermal Drug Delivery Market Size Markets, 2022 & 2030
4.1.2 Microfluidics
4.1.3 Smart Pill Technology (SPT)
4.2 By Type - Global Passive Transdermal Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Passive Transdermal Drug Delivery Revenue, 2018-2023
4.2.2 By Type - Global Passive Transdermal Drug Delivery Revenue, 2024-2030
4.2.3 By Type - Global Passive Transdermal Drug Delivery Revenue Market Share, 2018-2030
4.3 By Type - Global Passive Transdermal Drug Delivery Sales & Forecasts
4.3.1 By Type - Global Passive Transdermal Drug Delivery Sales, 2018-2023
4.3.2 By Type - Global Passive Transdermal Drug Delivery Sales, 2024-2030
4.3.3 By Type - Global Passive Transdermal Drug Delivery Sales Market Share, 2018-2030
4.4 By Type - Global Passive Transdermal Drug Delivery Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Passive Transdermal Drug Delivery Market Size, 2022 & 2030
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Passive Transdermal Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Passive Transdermal Drug Delivery Revenue, 2018-2023
5.2.2 By Application - Global Passive Transdermal Drug Delivery Revenue, 2024-2030
5.2.3 By Application - Global Passive Transdermal Drug Delivery Revenue Market Share, 2018-2030
5.3 By Application - Global Passive Transdermal Drug Delivery Sales & Forecasts
5.3.1 By Application - Global Passive Transdermal Drug Delivery Sales, 2018-2023
5.3.2 By Application - Global Passive Transdermal Drug Delivery Sales, 2024-2030
5.3.3 By Application - Global Passive Transdermal Drug Delivery Sales Market Share, 2018-2030
5.4 By Application - Global Passive Transdermal Drug Delivery Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Passive Transdermal Drug Delivery Market Size, 2022 & 2030
6.2 By Region - Global Passive Transdermal Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Passive Transdermal Drug Delivery Revenue, 2018-2023
6.2.2 By Region - Global Passive Transdermal Drug Delivery Revenue, 2024-2030
6.2.3 By Region - Global Passive Transdermal Drug Delivery Revenue Market Share, 2018-2030
6.3 By Region - Global Passive Transdermal Drug Delivery Sales & Forecasts
6.3.1 By Region - Global Passive Transdermal Drug Delivery Sales, 2018-2023
6.3.2 By Region - Global Passive Transdermal Drug Delivery Sales, 2024-2030
6.3.3 By Region - Global Passive Transdermal Drug Delivery Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Passive Transdermal Drug Delivery Revenue, 2018-2030
6.4.2 By Country - North America Passive Transdermal Drug Delivery Sales, 2018-2030
6.4.3 US Passive Transdermal Drug Delivery Market Size, 2018-2030
6.4.4 Canada Passive Transdermal Drug Delivery Market Size, 2018-2030
6.4.5 Mexico Passive Transdermal Drug Delivery Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Passive Transdermal Drug Delivery Revenue, 2018-2030
6.5.2 By Country - Europe Passive Transdermal Drug Delivery Sales, 2018-2030
6.5.3 Germany Passive Transdermal Drug Delivery Market Size, 2018-2030
6.5.4 France Passive Transdermal Drug Delivery Market Size, 2018-2030
6.5.5 U.K. Passive Transdermal Drug Delivery Market Size, 2018-2030
6.5.6 Italy Passive Transdermal Drug Delivery Market Size, 2018-2030
6.5.7 Russia Passive Transdermal Drug Delivery Market Size, 2018-2030
6.5.8 Nordic Countries Passive Transdermal Drug Delivery Market Size, 2018-2030
6.5.9 Benelux Passive Transdermal Drug Delivery Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Passive Transdermal Drug Delivery Revenue, 2018-2030
6.6.2 By Region - Asia Passive Transdermal Drug Delivery Sales, 2018-2030
6.6.3 China Passive Transdermal Drug Delivery Market Size, 2018-2030
6.6.4 Japan Passive Transdermal Drug Delivery Market Size, 2018-2030
6.6.5 South Korea Passive Transdermal Drug Delivery Market Size, 2018-2030
6.6.6 Southeast Asia Passive Transdermal Drug Delivery Market Size, 2018-2030
6.6.7 India Passive Transdermal Drug Delivery Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Passive Transdermal Drug Delivery Revenue, 2018-2030
6.7.2 By Country - South America Passive Transdermal Drug Delivery Sales, 2018-2030
6.7.3 Brazil Passive Transdermal Drug Delivery Market Size, 2018-2030
6.7.4 Argentina Passive Transdermal Drug Delivery Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Passive Transdermal Drug Delivery Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Passive Transdermal Drug Delivery Sales, 2018-2030
6.8.3 Turkey Passive Transdermal Drug Delivery Market Size, 2018-2030
6.8.4 Israel Passive Transdermal Drug Delivery Market Size, 2018-2030
6.8.5 Saudi Arabia Passive Transdermal Drug Delivery Market Size, 2018-2030
6.8.6 UAE Passive Transdermal Drug Delivery Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 3M
7.1.1 3M Company Summary
7.1.2 3M Business Overview
7.1.3 3M Passive Transdermal Drug Delivery Major Product Offerings
7.1.4 3M Passive Transdermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.1.5 3M Key News & Latest Developments
7.2 Actavis, Inc.
7.2.1 Actavis, Inc. Company Summary
7.2.2 Actavis, Inc. Business Overview
7.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Major Product Offerings
7.2.4 Actavis, Inc. Passive Transdermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.2.5 Actavis, Inc. Key News & Latest Developments
7.3 Bayer AG
7.3.1 Bayer AG Company Summary
7.3.2 Bayer AG Business Overview
7.3.3 Bayer AG Passive Transdermal Drug Delivery Major Product Offerings
7.3.4 Bayer AG Passive Transdermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.3.5 Bayer AG Key News & Latest Developments
7.4 Boehringer Ingelheim GmbH
7.4.1 Boehringer Ingelheim GmbH Company Summary
7.4.2 Boehringer Ingelheim GmbH Business Overview
7.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Major Product Offerings
7.4.4 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.4.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.5 Corium International, Inc.
7.5.1 Corium International, Inc. Company Summary
7.5.2 Corium International, Inc. Business Overview
7.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Major Product Offerings
7.5.4 Corium International, Inc. Passive Transdermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.5.5 Corium International, Inc. Key News & Latest Developments
7.6 Echo Therapeutics, Inc.
7.6.1 Echo Therapeutics, Inc. Company Summary
7.6.2 Echo Therapeutics, Inc. Business Overview
7.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Major Product Offerings
7.6.4 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.6.5 Echo Therapeutics, Inc. Key News & Latest Developments
7.7 GlaxoSmithKline plc
7.7.1 GlaxoSmithKline plc Company Summary
7.7.2 GlaxoSmithKline plc Business Overview
7.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Major Product Offerings
7.7.4 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.7.5 GlaxoSmithKline plc Key News & Latest Developments
7.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
7.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Summary
7.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Business Overview
7.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Major Product Offerings
7.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Key News & Latest Developments
7.9 Mylan N.V.
7.9.1 Mylan N.V. Company Summary
7.9.2 Mylan N.V. Business Overview
7.9.3 Mylan N.V. Passive Transdermal Drug Delivery Major Product Offerings
7.9.4 Mylan N.V. Passive Transdermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.9.5 Mylan N.V. Key News & Latest Developments
7.10 Novartis AG
7.10.1 Novartis AG Company Summary
7.10.2 Novartis AG Business Overview
7.10.3 Novartis AG Passive Transdermal Drug Delivery Major Product Offerings
7.10.4 Novartis AG Passive Transdermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.10.5 Novartis AG Key News & Latest Developments
7.11 Noven Pharmaceuticals, Inc.
7.11.1 Noven Pharmaceuticals, Inc. Company Summary
7.11.2 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Business Overview
7.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Major Product Offerings
7.11.4 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.11.5 Noven Pharmaceuticals, Inc. Key News & Latest Developments
7.12 Transdermal Corp.
7.12.1 Transdermal Corp. Company Summary
7.12.2 Transdermal Corp. Passive Transdermal Drug Delivery Business Overview
7.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Major Product Offerings
7.12.4 Transdermal Corp. Passive Transdermal Drug Delivery Sales and Revenue in Global (2018-2023)
7.12.5 Transdermal Corp. Key News & Latest Developments
8 Global Passive Transdermal Drug Delivery Production Capacity, Analysis
8.1 Global Passive Transdermal Drug Delivery Production Capacity, 2018-2030
8.2 Passive Transdermal Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global Passive Transdermal Drug Delivery Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Passive Transdermal Drug Delivery Supply Chain Analysis
10.1 Passive Transdermal Drug Delivery Industry Value Chain
10.2 Passive Transdermal Drug Delivery Upstream Market
10.3 Passive Transdermal Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Passive Transdermal Drug Delivery Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Passive Transdermal Drug Delivery in Global Market
Table 2. Top Passive Transdermal Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Passive Transdermal Drug Delivery Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Passive Transdermal Drug Delivery Revenue Share by Companies, 2018-2023
Table 5. Global Passive Transdermal Drug Delivery Sales by Companies, (K Units), 2018-2023
Table 6. Global Passive Transdermal Drug Delivery Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Passive Transdermal Drug Delivery Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Passive Transdermal Drug Delivery Product Type
Table 9. List of Global Tier 1 Passive Transdermal Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Passive Transdermal Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Passive Transdermal Drug Delivery Sales (K Units), 2018-2023
Table 15. By Type - Global Passive Transdermal Drug Delivery Sales (K Units), 2024-2030
Table 16. By Application ? Global Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Passive Transdermal Drug Delivery Sales (K Units), 2018-2023
Table 20. By Application - Global Passive Transdermal Drug Delivery Sales (K Units), 2024-2030
Table 21. By Region ? Global Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Passive Transdermal Drug Delivery Sales (K Units), 2018-2023
Table 25. By Region - Global Passive Transdermal Drug Delivery Sales (K Units), 2024-2030
Table 26. By Country - North America Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Passive Transdermal Drug Delivery Sales, (K Units), 2018-2023
Table 29. By Country - North America Passive Transdermal Drug Delivery Sales, (K Units), 2024-2030
Table 30. By Country - Europe Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Passive Transdermal Drug Delivery Sales, (K Units), 2018-2023
Table 33. By Country - Europe Passive Transdermal Drug Delivery Sales, (K Units), 2024-2030
Table 34. By Region - Asia Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Passive Transdermal Drug Delivery Sales, (K Units), 2018-2023
Table 37. By Region - Asia Passive Transdermal Drug Delivery Sales, (K Units), 2024-2030
Table 38. By Country - South America Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Passive Transdermal Drug Delivery Sales, (K Units), 2018-2023
Table 41. By Country - South America Passive Transdermal Drug Delivery Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Passive Transdermal Drug Delivery Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Passive Transdermal Drug Delivery Sales, (K Units), 2024-2030
Table 46. 3M Company Summary
Table 47. 3M Passive Transdermal Drug Delivery Product Offerings
Table 48. 3M Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. 3M Key News & Latest Developments
Table 50. Actavis, Inc. Company Summary
Table 51. Actavis, Inc. Passive Transdermal Drug Delivery Product Offerings
Table 52. Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Actavis, Inc. Key News & Latest Developments
Table 54. Bayer AG Company Summary
Table 55. Bayer AG Passive Transdermal Drug Delivery Product Offerings
Table 56. Bayer AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Bayer AG Key News & Latest Developments
Table 58. Boehringer Ingelheim GmbH Company Summary
Table 59. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Offerings
Table 60. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 62. Corium International, Inc. Company Summary
Table 63. Corium International, Inc. Passive Transdermal Drug Delivery Product Offerings
Table 64. Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Corium International, Inc. Key News & Latest Developments
Table 66. Echo Therapeutics, Inc. Company Summary
Table 67. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product Offerings
Table 68. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Echo Therapeutics, Inc. Key News & Latest Developments
Table 70. GlaxoSmithKline plc Company Summary
Table 71. GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Offerings
Table 72. GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. GlaxoSmithKline plc Key News & Latest Developments
Table 74. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Summary
Table 75. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product Offerings
Table 76. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Key News & Latest Developments
Table 78. Mylan N.V. Company Summary
Table 79. Mylan N.V. Passive Transdermal Drug Delivery Product Offerings
Table 80. Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Mylan N.V. Key News & Latest Developments
Table 82. Novartis AG Company Summary
Table 83. Novartis AG Passive Transdermal Drug Delivery Product Offerings
Table 84. Novartis AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Novartis AG Key News & Latest Developments
Table 86. Noven Pharmaceuticals, Inc. Company Summary
Table 87. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product Offerings
Table 88. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Noven Pharmaceuticals, Inc. Key News & Latest Developments
Table 90. Transdermal Corp. Company Summary
Table 91. Transdermal Corp. Passive Transdermal Drug Delivery Product Offerings
Table 92. Transdermal Corp. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Transdermal Corp. Key News & Latest Developments
Table 94. Passive Transdermal Drug Delivery Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 95. Global Passive Transdermal Drug Delivery Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Passive Transdermal Drug Delivery Production by Region, 2018-2023 (K Units)
Table 97. Global Passive Transdermal Drug Delivery Production by Region, 2024-2030 (K Units)
Table 98. Passive Transdermal Drug Delivery Market Opportunities & Trends in Global Market
Table 99. Passive Transdermal Drug Delivery Market Drivers in Global Market
Table 100. Passive Transdermal Drug Delivery Market Restraints in Global Market
Table 101. Passive Transdermal Drug Delivery Raw Materials
Table 102. Passive Transdermal Drug Delivery Raw Materials Suppliers in Global Market
Table 103. Typical Passive Transdermal Drug Delivery Downstream
Table 104. Passive Transdermal Drug Delivery Downstream Clients in Global Market
Table 105. Passive Transdermal Drug Delivery Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Passive Transdermal Drug Delivery Segment by Type in 2022
Figure 2. Passive Transdermal Drug Delivery Segment by Application in 2022
Figure 3. Global Passive Transdermal Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Passive Transdermal Drug Delivery Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Passive Transdermal Drug Delivery Revenue, 2018-2030 (US$, Mn)
Figure 7. Passive Transdermal Drug Delivery Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Passive Transdermal Drug Delivery Revenue in 2022
Figure 9. By Type - Global Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Passive Transdermal Drug Delivery Revenue Market Share, 2018-2030
Figure 11. By Type - Global Passive Transdermal Drug Delivery Sales Market Share, 2018-2030
Figure 12. By Type - Global Passive Transdermal Drug Delivery Price (USD/Unit), 2018-2030
Figure 13. By Application - Global Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Passive Transdermal Drug Delivery Revenue Market Share, 2018-2030
Figure 15. By Application - Global Passive Transdermal Drug Delivery Sales Market Share, 2018-2030
Figure 16. By Application - Global Passive Transdermal Drug Delivery Price (USD/Unit), 2018-2030
Figure 17. By Region - Global Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Passive Transdermal Drug Delivery Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Passive Transdermal Drug Delivery Revenue Market Share, 2018-2030
Figure 20. By Region - Global Passive Transdermal Drug Delivery Sales Market Share, 2018-2030
Figure 21. By Country - North America Passive Transdermal Drug Delivery Revenue Market Share, 2018-2030
Figure 22. By Country - North America Passive Transdermal Drug Delivery Sales Market Share, 2018-2030
Figure 23. US Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Passive Transdermal Drug Delivery Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Passive Transdermal Drug Delivery Sales Market Share, 2018-2030
Figure 28. Germany Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 29. France Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Passive Transdermal Drug Delivery Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Passive Transdermal Drug Delivery Sales Market Share, 2018-2030
Figure 37. China Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 41. India Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Passive Transdermal Drug Delivery Revenue Market Share, 2018-2030
Figure 43. By Country - South America Passive Transdermal Drug Delivery Sales Market Share, 2018-2030
Figure 44. Brazil Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Passive Transdermal Drug Delivery Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Passive Transdermal Drug Delivery Sales Market Share, 2018-2030
Figure 48. Turkey Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 52. Global Passive Transdermal Drug Delivery Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Passive Transdermal Drug Delivery by Region, 2022 VS 2030
Figure 54. Passive Transdermal Drug Delivery Industry Value Chain
Figure 55. Marketing Channels
